wsbdaily | Tue, 20 Dec 2022 03:11:26 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Kintara Therapeutics, Inc.(KTRA)
Kintara Therapeutics, Inc.
9920 Pacific Heights Blvd
Suite 150
San Diego, CA 92121
United States
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late stage pho... Read More
Summary & Charts
| Price | $ 8.86 | +2.16 (+32.23%) |
| Day's Range | $ 6.61 - 10.35 | |
| Previous Close | $ 6.70 | |
| Market Cap | $ 9.62M USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NasdaqCM | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 3.60M | |
| Avg. Volume (20 day) | 944.76K | |
| Rel. Volume (20 day) | 3.81 | |
| Rel. Volume (3 month) | 10.68 | |
| Rating | B | Neutral |
| DCF | N/A | Strong Buy |
| Debt/Equity | 37.35 % | Neutral |
| ROE | -192.91 % | Strong Sell |
| ROA | -163.93 % | Strong Sell |
| P/E | -13.78 % | Neutral |
| P/B | 1.35 % | Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Dec 01, 2022 | $ 6.61 | $ 10.35 | $ 6.61 | $ 8.86 | +2.16 | 3,595,933 | 3.81 | 10.68 | |
| Nov 30, 2022 | $ 5.71 | $ 7.00 | $ 5.53 | $ 6.70 | +0.75 | 1,985,694 | 2.59 | 7.30 | |
| Nov 29, 2022 | $ 4.24 | $ 6.17 | $ 4.23 | $ 5.95 | +1.59 | 2,116,115 | 3.17 | 8.86 | |
| Nov 28, 2022 | $ 4.65 | $ 4.90 | $ 4.06 | $ 4.36 | +0.67 | 9,787,122 | 17.41 | 47.69 | |
| Nov 25, 2022 | $ 3.57 | $ 3.74 | $ 3.52 | $ 3.69 | +0.04 | 32,502 | 0.44 | 0.55 | |
| Nov 23, 2022 | $ 3.81 | $ 4.25 | $ 3.50 | $ 3.65 | -0.10 | 228,913 | 3.12 | 3.87 | |
| Nov 22, 2022 | $ 4.20 | $ 4.20 | $ 3.73 | $ 3.75 | -0.46 | 76,000 | 1.20 | 1.35 | |
| Nov 21, 2022 | $ 4.02 | $ 4.37 | $ 4.00 | $ 4.21 | +0.20 | 65,900 | 1.08 | 1.17 | |
| Nov 18, 2022 | $ 3.89 | $ 4.30 | $ 3.73 | $ 4.01 | +0.12 | 78,800 | 1.32 | 1.37 | |
| Nov 17, 2022 | $ 3.77 | $ 3.97 | $ 3.71 | $ 3.89 | 46,200 | 0.81 | 0.81 | ||
| Nov 16, 2022 | $ 3.98 | $ 4.10 | $ 3.77 | $ 3.89 | -0.09 | 71,900 | 1.19 | 1.03 | |
| Nov 15, 2022 | $ 4.49 | $ 4.54 | $ 3.80 | $ 3.98 | -0.51 | 220,000 | 2.19 | 3.18 | |
| Nov 14, 2022 | $ 3.85 | $ 4.68 | $ 3.67 | $ 4.49 | +0.29 | 302,000 | 3.29 | 4.49 | 3 |
| Nov 11, 2022 | $ 4.45 | $ 4.45 | $ 3.75 | $ 4.20 | -1.00 | 156,792 | 2.02 | 2.45 | |
| Nov 10, 2022 | $ 4.90 | $ 5.60 | $ 4.60 | $ 5.20 | +0.65 | 24,276 | 0.34 | 0.39 | |
| Nov 09, 2022 | $ 5.00 | $ 5.00 | $ 4.40 | $ 4.55 | -0.25 | 20,834 | 0.30 | 0.33 | |
| Nov 08, 2022 | $ 5.10 | $ 5.25 | $ 4.50 | $ 4.80 | -0.20 | 35,770 | 0.51 | 0.56 | |
| Nov 07, 2022 | $ 5.15 | $ 5.65 | $ 4.85 | $ 5.00 | -0.30 | 27,186 | 0.39 | 0.42 | |
| Nov 04, 2022 | $ 5.10 | $ 5.75 | $ 5.10 | $ 5.30 | +0.05 | 13,644 | 0.20 | 0.21 | |
| Nov 03, 2022 | $ 5.35 | $ 5.40 | $ 5.05 | $ 5.25 | +0.05 | 9,676 | 0.14 | 0.15 |
News
The latest news about Kintara Therapeutics, Inc. (KTRA).
PennyStocks | 2022-10-20 06:00:00
Can these penny stocks trading tips help your strategy? The post 3 Strategies for Buying and Selling Penny Stocks Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-11-09 | BMO | -- | -- | -- | -- | -- | -- |
| 2022-09-27 | BMO | -1.5 | -5.50 | 266.66% | 4.7M | -- | -- |
| 2022-05-13 | BMO | -7.5 | -5.50 | 26.67% | -- | -- | -- |
| 2022-02-11 | BMO | -9 | -6.00 | 33.34% | -- | -- | -- |
| 2021-11-15 | BMO | -7.000000000000001 | -8.50 | 21.42% | -- | -- | -- |
| 2021-09-29 | BMO | -8 | -6.50 | 18.75% | -- | -- | -- |
| 2021-05-14 | BMO | -9 | -11.50 | 27.77% | -- | -- | -- |
| 2021-02-12 | BMO | -7.000000000000001 | -11.00 | 57.14% | -- | -- | -- |
Top Discussions
These are the top discussions over the last 24-hours that mention the KTRA stock ticker symbol.
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Mon, 13 Dec 2021 12:00 EST
@wsbdaily
wsbdaily